Unique ID issued by UMIN | UMIN000012807 |
---|---|
Receipt number | R000014954 |
Scientific Title | Japanese study of Anti-ccp antibody SCreENing methoD in general health check up |
Date of disclosure of the study information | 2014/01/10 |
Last modified on | 2023/01/18 09:28:05 |
Japanese study of Anti-ccp antibody SCreENing methoD in general health check up
J-ASCEND
Japanese study of Anti-ccp antibody SCreENing methoD in general health check up
J-ASCEND
Japan |
Rheumaid Arthritis
Clinical immunology |
Others
NO
To evaluate diagnostic performance of anit-CCP antibody test as a
screening test at medical health checkup in general population.
Others
To evaluate the impact of anti-CCP antibody screening on patients'
outcome and its economic effect.
Others
Others
Not applicable
The positivity rate of anti-CCP antibody in general population and
number of the patients who are diagnosed as rheumatoid arthritis by
this screening method.
Patients' outcome and economic effect of anti-CCP antibody screening test.
Observational
20 | years-old | <= |
Not applicable |
Male and Female
We check anti-CCP antibody in people who visits our health check up institutions and agree to the test.
Patients who already has been diagnosed as rheumatoid arthritis or who disagrees to this study are excluded.
25000
1st name | Masato |
Middle name | |
Last name | Okada |
St.Lukes International Hospital
Division of Allergy and Rheumatology
1048560
9-1 Akashi-cho, Chuo-Ku, Tokyo
03-3541-5151
bestlupusdoctorever@gmail.com
1st name | Masato |
Middle name | |
Last name | Masato |
St.Lukes International Hospital
Division of Allergy and Rheumatology
1049560
9-1 Akashi-cho, Chuo-Ku, Tokyo
03-3541-5151
bestlupusdoctorever@gmail.com
St.Lukes International Hospital
Ministry of Health, Labour and Welfare
Japanese Governmental office
SLIH
9-1Akashi-cho
0335415151
bestlupusdoctorever@gmail.com
NO
2014 | Year | 01 | Month | 10 | Day |
none
Unpublished
none
1500
RA
2023 | Year | 01 | Month | 18 | Day |
DOCK
DOCK
None
RA
Completed
2013 | Year | 04 | Month | 01 | Day |
2013 | Year | 03 | Month | 01 | Day |
2013 | Year | 11 | Month | 01 | Day |
2015 | Year | 03 | Month | 31 | Day |
After obtainig the consent, they were collected serum samples. Anti-CCP antibody and rheumatoid factor are examined. Antibody-positive persons are examined by Rheumatologists directly, and classified as follows; 1. Early RA group: the person with the diagnosis of rheumatoid arthritis, 2. Pre-RA groups: the person with joint symptoms, 3. Non-RA group: the person with no symptoms. Then they are followed up at regular intervals. For early RA group, its treatment is done by Rheumatologist in line with guidelines. When they develop rheumatoid arthritis, they will be treated as in the early RA group. After this study started, disease activity measure (CDAI, SDAI, DAS28, DAS28-CRP), ADL(HAQ-DI), X ray evaluation (modified Total Sharp Score), and medical cost will be checked annualy.
2014 | Year | 01 | Month | 09 | Day |
2023 | Year | 01 | Month | 18 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000014954
Research Plan | |
---|---|
Registered date | File name |
Research case data specifications | |
---|---|
Registered date | File name |
Research case data | |
---|---|
Registered date | File name |